Single incretin receptor knockout mice do not compensate by increasing glucose-stimulated secretion of the remaining incretin hormone.

Abstract

Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are incretin hormones. Lack of GLP-1 receptor signaling has been reported to be compensated for by increased GIP secretion and action. Conversely GLP-1 sensitivity has been reported to be increased in GIP receptor knockout (Gipr^-/-) mice. This suggests a compensatory adaptation to loss of incretin signaling via increased action/secretion of the remaining incretin hormone. We assessed glucose-stimulated GIP and GLP-1 secretion during oral glucose tolerance tests (OGTTs) and in isolated perfused intestines of GLP-1 receptor knockout (Glp-1r^-/-) mice and their wild-type littermates (Glp-1r^+/+) and in Gipr^-/- mice and their wild-type littermates (Gipr^+/+). Sensitivity to GIP and GLP-1 was assessed in isolated perfused pancreases of Glp-1r^-/- and Glp-1r^+/+ mice and Gipr^-/- and Gipr^+/+ mice, respectively. We found similar GIP responses in Glp-1r^-/- and Glp-1r^+/+ mice and similar GLP-1 responses in Gipr^-/- and Gipr^+/+ mice during the OGTTs and in the isolated perfused intestines. Insulin responses to GIP and GLP-1 were similar in Glp-1r^-/- and Glp-1r^+/+ mice and in Gipr^-/- and Gipr^+/+ mice, respectively. Our results do not support the existence of a compensatory adaptation to loss of single incretin signaling via increased glucose-stimulated secretion of, or sensitivity to, the remaining incretin hormone.